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Mononuclear phagocytes are a widely distributed sys-
tem of cells involved in host defense functions, immu-
nologic reactions, disposal of unwanted organic and in-
organic materials, and synthesis of biologically active 
compounds such as complement components and pros-
taglandins. The system includes early precursor cells in 
the bone marrow, blood monocytes, alveolar and peri-
toneal macrophages, sinusoidal lining cells in the spleen, 
and Kupffer cells in the liver. We have recently come to 
understand the biology of these interesting cells and the 
diseases they produce. 
Mononuclear phagocytes constitute a cell line that includes 
monoblasts and promonocytes in the bone marrow, the mono-
cyte as a cell of intermediate differentiation in the blood, and 
mature macrophages in the tissues. Tissue macrophages are 
heterogeneous and include free alveolar and peritoneal macro-
phages, Kupffer cells, and the macrophages of the splenic 
sinusoids. The concept of a continuum of cells from bone 
marrow precursors to the mature tissue macro phages is impor-
tant to an understanding of the function and metabolism of 
these cells. 
MATURATION OF MONONUCLEAR PHAGOCYTES 
Mononuclear phagocytes share a common progenitor cell 
with the granulocytic series. The earliest cells of these series 
are undifferentiated lymphocyte-like cells [1]. When undiffer-
entiated monoblasts mature and form a complex Golgi appa-
ratus and a definite granule population, they are identifiable 
and are designated promonocytes. The promonocyte has a high 
nucleus-to-cytoplasm ratio, basophilic cytoplasm, and some 
peroxidase activity. The cell generally shows little phagocytic 
activity. With maturation to the monocyte level, the activity of 
certain acid hydrolases and the phagocytic ability increase 
[2,3]. 
Tissue macrophages (synonym: histiocytes) are later stages 
of maturation of monocytes. They are large cells 20 to 80 !Lm in 
diameter, with one or more large vesicular nuclei and abundant 
cytoplasmic lysosomes, numerous mitochondria, and other in-
clusions. The cells move slowly, and the movement appears to 
depend on the complex of microfllaments. Immature macro-
phages are capable of DNA synthesis and cell division, but 
ultimately immature cells give rise to mature nondividing mac-
rophages. These macrophages may form multinucleate giant 
cells, probably by the process of cell fusion. These giant cells, 
seen in chronic granulomatous reactions, are rich in lysosomes 
and hyd.rolytic enzymes. 
KINETICS OF MONONUCLEAR PHAGOCYTES 
The studies of Meuret, Bammert, and Hoffmann [4,5] indi-
cate the following: (i) normally blood monocyte counts oscillate 
with a cycle frequency of 3 to 6 days, (ii) the total blood 
monocyte pool comprises a circulating pool and a marginated 
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pool in a ratio of 1:3, (iii) monocytes leave the blood exponen-
tially with a half life of 8.4 hr, (iv), the half life may be prolonged 
in patients with monocytosis and shortened in patients with \ 
acute infection or splenomegaly, and (v) the normal monocyte 
turnover rate averages 7 X lOG cells pel' hour pel' kilogram of 
body weight. 
Available data suggest that there is no significant reentry of 
monocytes into the bloodstream once they have left the circu-
lation. They enter the tissues and mature to macrophages. The 
major source of mononuclear phagocytes accumulating at in-
flammatory foci is the monocyte precursors of the bone marrow 
[6]. Under noninflammatory conditions tissue macrophages 
may also arise from endogenous replicating cell populations, as 
well as from man-ow precursors [7]. 
METABOLISM OF MONONUCLEAR PHAGOCYTES 
The metabolism and enzymatic activities of mononuclear \ 
phagocytes change profoundly with cell maturation and with 
changes in cellular environment [2,8]. The principal energy 
source for human monocytes and for most tissue macrophages 
is glycolysis, even under aerobic conditions. In contrast, the 
metabolism of the nonphagocytic human alveolar macrophage 
appears to be primaril'y aerobic [2,9]. 
Macrophages have an active lipid metabolism, and phospho-
lipid synthesis is increased during phagocytosis. The more 
mature cells of the series have abundant rough endoplasmic 
reticulum and a high rate of protein synthesis. Much of this 
synthetic activity is directed toward the production oflysosomal 
enzymes, but other biologically active compounds, such as 
complement components, are also made in these cells. 
The many hydrolytic enzymes localized within the lysosomal I 
cell fraction [2] probably have a major role in the digestion of 
phagocytized organic materials, including erythrocytes and mi- \ 
croorganisms. Some lysosomal enzymes may also be secreted 
by macro phages [10]. 
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The transformation from monoblast to mature macrophage 
is associated with changes in cellular composition and m e-
tabolism. With maturation, the number of cytoplasmic lyso-
somes and mitochondria increases, and the activity levels of 
associated lysosomal and mitochondrial enzymes change Cor- \ 
respondingly. Differentiation to mature macrophages and the 
accompanying increase in specific activity of certain lysosomal 
enzymes are dependent on intact protein synthesis. When mac-
rophages are cultivated in vitro under circumstances in which 
pinocytic activity is reduced, the many secondary lysosome 
gradually disappear from the cytoplasm. Such influence of \ 
environmental factors on the cellular level oflysosomal enzymes 
seen in vitro probably reflects the situation in the intact animal 
in which the functional status of the macrophages is adaptable. 
This phenomenon is most clearly demonstrated in macro phages 
"activated" by infection with an intracellular parasite, such a 
Mycobacterium tuberculosis. These mononuclear phagocyte 
are larger, spread more readily on a sUlface, and have increased \ 
metabolic and microbicidal activity. Activation is thought to be 
mediated by products of sensitized lymphoid cells [11]. \ 
FUNCTIONS OF MONONUCLEAR PHAGOCYTES 
Five major areas of mononuclear phagocyte function have 
been identified: (i) defense against microorganisms, (ii) removal 
of dead or damaged cells, cell debris, and inorganic material , \ 
(iii) cooperative and effector functions in immune responses, 
\ 
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(iv) regulatory interactions in hematopoiesis, and (v) synthesis 
of other biologically active compounds, such as complement 
components and prostaglandins. These cells may also play a 
role in wound repair and remodeling of embr~'onic tissues. 
DEFENSE AGAINST MICROORGANISMS 
Monocytes and macrophages have an important role in the 
defense against a variety of infectious organisms [2,8,12]. They 
are the principal cells involved in killing intracellulaj' parasites 
such as Mycobacteria, Listeria, and Toxoplasma [13]. Macro-
phages participating with immunocompetent cells may also kill 
virus and virus-infected cells, and have been demonstrated to 
produce interferon and to enhance lymphocyte production of 
interferon. 
Mononuclear phagocytes are chemotactically attracted to an 
infective focus, where they phagocytize the invading organism. 
The activated fifth component of complement, as well as factors 
released by mitogen- and antigen-stimulated lymphocytes are 
chemotactic for monocytes. 
Macrophages may accumulate at an infective focus under the 
influence of another lymphocyte-derived factor, migration-in-
hibiting factor. This factor may be the same molecule that 
activates macrophages (macrophage-activating factor) and is 
probably one of the inducers of the complex series of metabolic 
changes that result in the "activated" state [14]. 
The precise mechanisms by which mononuclear phagocytes 
kill ingested microorganisms have not been clearly defined, but 
they probably involve both oxygen-dependent and -indepen-
dent cell functions [15]. Activated macrophages have been 
shown to kill some microorganisms more efficiently than non-
activated cells. Monocytes from patients with chronic granu-
lomatous disease (CGD) manifest defective bactericidal and 
fungicidal capacities. Since the defect in CGD is related to 
impaired H 20 2 and O2- generation, it is likely that mononuclear 
phagocytes share this microbicidal mechanism with granulo-
cytes [15]. 
REMOVAL OF DAMAGED CELLS AND INORGANIC 
MATERIALS 
Mononuclear phagocytes remove damaged or dying cells. 
Macrophages seem able to recognize alterations in the eryth-
rocyte surface caused by antibody, physical or chemical injUl'Y, 
or aging. Splenic macrophages remove nuclear remnants and 
precipitated hemoglobin from circulating erythrocytes ("pit-
ting"). They also ingest immunologically injUl'ed leukocytes 
and platelets. Alveolar macrophages have a special function in 
clearing particulate material from inspired air [7). 
Macrophages also localize various inorganic materials within 
tissues. Beryllium, zirconium, and silica cause granulomatous 
tissue reactions, and silica is known to be highly toxic to 
macrophages. 
COOPERA TIVE FUNCTIONS IN IMMUNE RESPONSES 
Mononuclear phagocytes play an important role in both cell-
mediated and humoral immunity [11,16]. They operate both in 
the afferent limb of the immune response in antigen processing 
and in the efferent limb as effector cells. Monocytes and mac-
rophages collect, catabolize, and eliminate certain potentially 
immunogenic materials and retain other immunogenic mole-
cules. Mononuclear phagocytes then can selectively present 
antigen to immunocompetent T and B lymphoid cells [16]. 
Antigen taken up by macrophages is partially degraded in 
phagolysosomes, but a small fraction may be retained in its 
native state for long periods of time [16]. Close contact between 
mononuclear phagocytes and lymphocytes is apparently impor-
tant in the transfer of immunologic information and initiation 
of the immune response [2,17-19]. 
Macrophages and subclasses of T lymphocytes must interact 
with certain types of antigen before a maximal B lymphocyte 
response can be expressed. Similarly, optimal T lyml?hocyte 
proliferative response to mitogen and the generation of helper 
T cells requires interaction with macro phages [20]. Macrophage 
interactions with T cells are complex and require cells that are 
genetically compatible. 
In summary, it is apparent that lymphoid cells may activate 
macrophages and that macrophages may activate and direct 
lymphocytes. 
CELL-MEDIATED CYTOTOXICITY AND ANTITUMOR 
IMMUNITY 
The role of monocytes and macrophages in the control of 
neoplasia is of considerable interest but is still uncertain [21]. 
It is thought that mononuclear phagocytes may act as effector 
cells in various cytotoxic reactions. One form is referred to as 
antibody-dependent, cell-mediated cytotoxicity (ADCC). This 
mechanism depends on the coating of target cells with specific 
antibody and subsequent identification and destruction by ef-
fector cells. Mononuclear phagocytes, as well as granulocytes, 
can function in ADCC [22]. Macrophage recognition of anti-
body-coated target cells depends on membrane receptors for 
the Fc portion of subclasses of IgG antibody. 
Monocytes and macrophages also participate in cytotoxic 
reactions mediated by humoral antibody (cytophilic antibody) 
that attaches first to the effector cells. This type of antitumor 
cell activity is specific, is mediated by humoral antibody, and is 
effective in initiating macrophage cytotoxicity against neoplas-
tic cells [23]. A third form of macrophage tumoricidal mecha-
nisms is mediated by a nonimmunoglobulin humoral factor 
derived from immune lymphocytes. This material, referred to 
as specific macrophage-activating factor, apperu's to act in a 
manner similru' to that of cytophilic antibody [23]. 
Nonspecifically activated macrophages can also kill syngeneic 
tumor cells [24], a phenomenon that has been demonstrated 
both in vitro and in vivo. Nonspecific macrophage activation 
occurs with intracellular parasitosis, such as Toxoplasma or 
tuberculosis infection, and in response to certain other biologi-
cal materials such as phytohemagglutinin, endotoxin, pyran 
copolymer, and glucan. Nonspecific activation may be mediated 
by a vru'iety of lymphocyte products (lymphokines) [14]. 
Activated cells ru'e larger, spread more on glass, and have a 
greater number of lysosomal particles than unactivated cells. 
Certain of their enzyme activities are decreased; others ru'e 
increased. They are better killer cells. 
The mechanisms by which activated macrophages kill tumor 
cells are not well understood. Killing requires intact energy 
production but is independent of DNA, RNA, or protein syn-
thesis. Cytotoxicity does not depend on phagocytosis, but close 
cell-to-cell contact is necessru-y. Transfer of lysosomal material 
may be important in the killing process [25], and we have 
recently demonstrated that in at least some tumor model sys-
tems the killing process is oxygen-independent [26]. 
CONTROL OF GRANULOPOIESIS 
Monocytes and macrophages may have a regulatory role in 
granulopoiesis related to their elaboration of a humoral factor. 
The formation of granulocyte and monocyte colonies in semi-
solid gel cultUl'e is dependent on the presence of stimulating 
substances collectively called colony-stimulating activity (CSA) 
[27]. Although there is considerable biochemical heterogeneity 
associated with this activity, the best chru'acterized materials 
are glycoproteins. In man, the main sources of CSA apperu' to 
be circulating monocytes and tissue macrophages [28,29]. 
Mononuclear phagocytes may thus regulate the production of 
granulocytes, as well as their own production. Monocyte CSA 
elaboration can be increased by endotoxin and certain nucleo-
tides. 
The role of monocytes and macrophages in the regulation of 
granulopoiesis is still uncertain and will become clearer when 
the physiological importance of CSA has been better defined. 
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MONONUCLEAR PHAGOCYTE DYSFUNCTION 
SYNDROMES 
Alt hough granulocyte functional disorders have been well 
described, relatively little is known about functional diseases of 
monocytes and macrophages. Defects in monocyte chemotaxis 
are reported in some patients with cancer and in patients and 
animals with Chediak-Higashi syndrome. Monocyte accumu-
lation in skin windows is impaired by corticosteroids in man. 
Monocytes from patients with chronic granulomatous disease 
have defective bactericidal and fungicidal capacities [15]. In the 
rare genetic deficiency of myeloperoxidase, the monocytes also 
have a defective fungicidal capacity, but macrophage killing is 
normal. 
Defective monocyte microbicidal function has been demon-
strated in patients with acute myelomonocytic leukemia, in 
some patients with lymphoma, and in patients with certain 
types of vil'al infections [2]. An acquired defect of human 
alveolal' function has been delineated in pulmonal'Y alveolal' 
proteinosis [30], and recently my colleague, Dr. Territo, has 
demonstrated a defect in monocyte killing activity after bone 
marrow transplantation. The common featul'e of all these dis-
orders is an enhanced susceptibility to microbial infection. 
MALIGNANT MONONUCLEAR PHAGOCYTES 
An understanding of the neoplastic disorders of monocytes 
and macrophages has been hampered by a cumbersome no-
menclature. Nevel'theless, we are beginning to understand these 
diseases in terms of modern cell biology [31]. 
Acute monocytic and myelomonocytic leukemia are types of 
acute leukemia in which there is a proliferation of hematopoi-
etic cells with sufficient differentiation to exhibit characteristics 
of the mononuclear phagocyte line. Often, a variable admixtUl'e 
of granulocytic elements, probably related to the close associa-
tion of the stem cells of these cell lines, is present. Acute 
monocytic leukemia cells exhibit morphological and functional 
matUl'ation ranging from blast cells to phagocytic cells with the 
characteristics of macro phages [2]. They usually contain the 
nonspecific esterase characteristic of monocytes and macro-
phages, adhere to glass, may be highly phagocytic, and elabo-
rate substantial quantities of CSA and lysozyme. A chronic 
form of myelomonocytic leukemia is also recognized [32]. 
Histiocytic lymphoma has classically been considered as a 
neoplastic proliferation of mononuclear phagocytes. Recent 
studies, however, suggest that many of the previously described 
histiocytic lymphomas are in fact large-cell ("immunoblastic") 
lymphocytic malignant tumors. Nevertheless, histiocytic lym-
phomas do occul' where the proliferating cells appear to be of 
the monocyte-macrophage line. 
The malignant histiocytoses include Letterer-Siwe disease in 
children and histiocytic medullary reticulosis in adults. These 
disorders are fairly well-defined clinical entities characterized 
by the proliferation of moderately differentiated mononuclear 
phagocytes in lymph nodes, bone marrow, and spleen, and often 
in skin and lung [2]. Erythrophagocytosis and thrombophago-
cytosis are common and may lead to severe peripheral cytopen-
ias. Hemophagocytic reticulosis is a poorly understood but 
similar disorder seen in children. 
SUMMARY 
The mononuclear phagocyte cell line has several morpholog-
ically defined cell types at different levels of maturation, in-
cluding promonocytes, monocytes, and tissue macro phages. 
Each of these has a characteristic composition, function, and 
metabolism. Mononuclear phagocytes are involved in "house-
keeping" functions, in microbicidal defense, and in the afferent 
and efferent limbs of the immune response. They may interact 
with many other cells in hematopoiesis. Disorders of mononu-
clear phagocyte function and differentiation have been identi-
fied. These include (i) storage diseases based on macrophage 
enzyme deficiencies, (ii) defects in macrophage chemotaxis or 
Vol. 71, No.1 
microbicidal activity, and (iii) malignant transformation of 
mononuclear phagocytes. 
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